Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
- 1Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil
- 2Nathan Portela Institute of Tropical Medicine, Federal University of Piauí, Teresina, Brazil
A Corrigendum on
Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
by de Miranda Santos IKF and Costa CHN (2020). Front. Immunol. 11:1739. doi: 10.3389/fimmu.2020.01739
In the original article, we neglected to include the funder Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Grant Number 2020/09093-5 to IM.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: COVID-19, Sars-CoV-2, coronavirus, antibodies, hydroxychloroquine
Citation: Santos IKFDM and Costa CHN (2020) Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus. Front. Immunol. 11:615628. doi: 10.3389/fimmu.2020.615628
Received: 09 October 2020; Accepted: 12 October 2020;
Published: 02 November 2020.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2020 Santos and Costa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Isabel Kinney Ferreira De Miranda Santos, aW1zYW50b3NAZm1ycC51c3AuYnI=